About us

Biograil™ was established in 2019 and is a pre-clinical stage pharmaceutical company leveraging its proprietary BIONDD™ technology to unlock the potential of transforming markets of injectable pharmaceutical products into convenient oral capsules.

Our Team

Karsten Lindhardt, CEO & Founder

Nikolaj Skak, CTO & Founder

Kamille Dumong Erichsen, Non-Clinical Project Director

Nils Piwon, Portfolio and Alliance Director

Martin Rex Olsen, Manufacturing Director

Lisbeth Nordly Lauritzen, PA